Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size

BACKGROUND: The treatment schedules for stereotactic body radiotherapy (SBRT) for lung cancer vary from institution to institution. Several reports have indicated that stage IB patients had worse outcomes than stage IA patients when the same dose was used. We evaluated the clinical outcomes of SBRT...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Baba, Fumiya, Shibamoto, Yuta, Ogino, Hiroyuki, Murata, Rumi, Sugie, Chikao, Iwata, Hiromitsu, Otsuka, Shinya, Kosaki, Katsura, Nagai, Aiko, Murai, Taro, Miyakawa, Akifumi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2010
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2955592/
https://ncbi.nlm.nih.gov/pubmed/20849623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-5-81
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak